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Introduction: The purpose of this study was to evaluate the clinical relevance of high values of central venous-to-
arterial carbon dioxide difference (PCO2 gap) in high-risk surgical patients admitted to a postoperative ICU. We
hypothesized that PCO2 gap could serve as a useful tool to identify patients still requiring hemodynamic optimization
at ICU admission.
Methods: One hundred and fifteen patients were included in this prospective single-center observational study during
a 1-year period. High-risk surgical inclusion criteria were adapted from Schoemaker and colleagues. Demographic and
biological data, PCO2 gap, central venous oxygen saturation, lactate level and postoperative complications were recorded
for all patients at ICU admission, and 6 hours and 12 hours after admission.
Results: A total of 78 (68%) patients developed postoperative complications, of whom 54 (47%) developed organ
failure. From admission to 12 hours after admission, there was a significant difference in mean PCO2 gap (8.7 ± 2.8 mmHg
versus 5.1 ± 2.6 mmHg; P = 0.001) and median lactate values (1.54 (1.1-3.2) mmol/l versus 1.06 (0.8-1.8) mmol/l; P = 0.003)
between patients who developed postoperative complications and those who did not. These differences were maximal
at admission to the ICU. At ICU admission, the area under the receiver operating characteristic curve for occurrence of
postoperative complications was 0.86 for the PCO2 gap compared to Sequential Organ Failure Assessment score (0.82),
Simplified Acute Physiology Score II score (0.67), and lactate level (0.67). The threshold value for PCO2 gap was 5.8 mmHg.
Multivariate analysis showed that only a high PCO2 gap and a high Sequential Organ Failure Assessment score were
independently associated with the occurrence of postoperative complications. A high PCO2 gap (≥6 mmHg) was
associated with more organ failure, an increase in duration of mechanical ventilation and length of hospital stay.
Conclusion: A high PCO2 gap at admission in the postoperative ICU was significantly associated with increased
postoperative complications in high-risk surgical patients. If the increase in PCO2 gap is secondary to tissue hypoperfusion
then the PCO2 gap might be a useful tool complementary to central venous oxygen saturation as a therapeutic target.Introduction
There is increasing evidence that individually optimized
hemodynamic therapy oriented on goals to maintain and
improve tissue perfusion and/or oxygenation improves
patient outcome [1]. The development of tissue hypoxia is
a leading cause of postoperative organ failure and mortality
following major surgery [2,3]. Early recognition and
correction of warning signals of persistent inadequacy of* Correspondence: emmanuel.robin@chru-lille.fr
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cially in patients with a reduced physiological reserve [1,4].
The inability to meet an increase in oxygen (O2) demand
with surgical trauma either by an increase in O2 delivery or
an increase in O2 extraction can lead to tissue hypoxia
[5,6]. Several markers of impaired tissue oxygenation have
been explored to help identify patients at increased risk of
complications. Postoperative organ failure has been shown
to be associated with reduced central venous O2 saturation
(ScvO2), which explores the balance of O2 delivery and
tissue O2 consumption [7]. However, there is evidence that
O2-derived variables are poorly correlated with anaerobicicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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Age ≥70 years 42 (37)
ASA class ≥3 70 (61)
Severe nutritional problems 11 (10)
Previous severe respiratory illness 24 (11)
Chronic renal failure 6 (5)
Chronic liver failure 7 (6)
Ischemic heart disease (infarction or angina) 51 (44)
Malignant neoplasia 67 (58)
Surgical criteria
Major abdominal surgery 82 (71)
Prolonged surgery ≥8 hours 9 (8)
Urgent surgery 22 (19)
Septic surgery 24 (21)




Small bowel resection 17 (15)
Large bowel resection 20 (17)
Hepatectomy 21 (18)
Pancreatectomy 16 (14)




Acute respiratory failure 32 (28)
Hemorrhage (hemoglobin <7 g/dl) 10 (9)
Acute coronary syndrome 7 (6)
Data are presented as absolute value (%). Severe nutritional problems: body mass
index ≤17 kg/m2 or weight loss >10% in 6 months. Chronic renal failure: creatinine
clearance <60 ml/min per 1.73 m2 or creatinine >176 μmol/l. Chronic liver failure:
bilirubin >78 μmol/l or prothrombin time <55% or well-documented cirrhosis.
ASA, American Society of Anesthesiology physical status.
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(that is, ≥75%) for ScvO2 do not preclude the presence of
tissue hypoxia in case of impaired O2 extraction
capabilities, which may therefore limit the usefulness
of ScvO2 monitoring [12,13]. In contrast, it has also
been shown that strategies aimed at reducing high
serum lactate levels, as a warning signal of a persistent
tissue hypoxia at ICU admission, could reduce length of
stay and mortality [14,15]. However, a rise in lactate
level may be delayed compared with markers of tissue
oxygenation adequacy, such as oxygen extraction [16],
and could be not sensitive enough to reflect tissue
hypoperfusion [14].
Previous relatively small studies have proposed central
venous-to-arterial carbon dioxide gradient (PCO2 gap), a
global index of tissue perfusion, as a useful measurement
to characterize the insufficient flow state in spite of
apparently normal macrocirculatory parameters [17,18].
Tissue partial pressure of carbon dioxide (PCO2) reflects
metabolic alterations due to inadequate perfusion in
actively metabolized tissues [19]. The PCO2 gap, which
has been shown to be inversely related to cardiac output
(CO) [20], is considered as a marker of the ability of the
venous blood flow to remove the CO2 excess produced
in tissues [21]. Thus, an impaired tissue perfusion during
a reduced blood flow is the main determinant of a rise
of the PCO2 gap [22]. However, despite promising findings
from both experimental and clinical data, the prognostic
significance of the PCO2 gap has only been examined to a
small extent in the context of major surgical trauma. The
purpose of this study was to evaluate the clinical relevance
of high values of the PCO2 gap, and their relationships to
other markers of impaired tissue perfusion and oxygenation
(that is, blood lactate and ScvO2). We hypothesized that
the PCO2 gap could serve as a useful tool to help identify
patients at high risk of postoperative complications at ICU
admission following major surgery.
Methods
Patients
This was a prospective single-center observational study
of patients scheduled for major abdominal and vascular
surgery and admitted to the ICU of a University Hospital
over a 1-year period. The study was approved by local
Research Ethics Committee of the University Hospital of
Lille, France, which permitted anonymous data analysis.
The requirement for written inform consent was waived
due to the strict observational design of this study.
Inclusion criteria adapted from Schoemaker and
colleagues [23] are summarized in Table 1 and are divided
into demographic, surgical and intensive care criteria. All
patients undergoing abdominal or vascular surgery
were included if they had one of the following criteria: 1)
one demographic criterion and one surgical criterion; 2)three or more demographic criteria; 3) three or more sur-
gical criteria; 4) one intensive care criterion.
Study protocol
As part of our routine hemodynamic monitoring during
major surgery, all patients were monitored with central
venous (standard two-lumen catheter, Arrow, Wayne,
Pennsylvania, USA; or PreSep catheter with oximetry, Ed-
wards Lifesciences, Irvine, California, USA) and arterial
(Seldicath, Plastimed, Le Plessis Bouchard, France) cathe-
ters placed before the beginning of surgery. The central
venous line was positioned with the tip within the superior
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radiograph. Until admission to the ICU, anesthesia and sur-
gical procedures were performed according to the local
standards. No specific hemodynamic protocol was used
during surgery. All patients were admitted to the ICU
immediately after surgery and were all managed according
to our local standards of care.
Data collection and outcome measures
Standard postoperative monitoring included: electrocar-
diograph (heart rate), invasive mean arterial pressure,
pulse oxymetry and urine output. In all patients, the
PCO2 gap, calculated as the difference between central
venous partial pressure of carbon dioxide and arterial
partial pressure of carbon dioxide, ScvO2, serum lactate
level, blood gas analysis, troponin I and routine laboratory
tests were obtained by intermittent blood sampling immedi-
ately after admission (H0) and repeated 6 (H6) and 12 hours
(H12) later. At ICU admission, data on demographics
(age, sex, weight), type of surgical procedure, American
Society of Anesthesiology Physical Status score, Simplified
Acute Physiology Score (SAPS) II [24], presence of
catecholamine and the need for mechanical ventilation were
recorded in all patients. Postoperative organ failure was
assessed using the Sequential Organ Failure Assessment
(SOFA) score recorded daily until ICU discharge.
Briefly, the organ failure criteria are:
 Circulatory failure: use of catecholamine to maintain
a mean arterial pressure ≥65 mmHg after a suitable
fluid loading.
 Acute respiratory failure: need for mechanical
ventilation or noninvasive ventilation.
 Acute kidney injury: 1.5-times increase in creatinine
serum level or increased creatinine >0.3 mg/dl or
urine output <0.5 ml/kg per hour for 6 hours.
 Neurological impairment: stroke with focal deficit or
coma (Glasgow score ≤8) or delirium.
Postoperative complications were assessed in accordance
with previously defined criteria [25,26] until hospital dis-
charge or death as follows: postoperative sepsis (pneumonia,
intraperitoneal abscess, wound infection, peritonitis and
urinary tract infection), acute respiratory failure, acute
renal and cardiac failures, postoperative hemorrhage,
ischemic events, and postoperative mortality. Patients
were followed-up until hospital discharge or death.
Statistical analysis
The study population was divided into two groups
according to the occurrence of postoperative complications.
Normal distribution of all variables was accessed by graph-
ical methods and the Kolmogorov-Smirnov test. All data
are presented as absolute value (%), as mean ± standarddeviation or as median (interquartile range) when neces-
sary. Differences between the two groups at baseline were
analyzed using the Student’s t test or Mann-Whitney U
test for continuous variables, and chi-square test or Fish-
er’s exact test for categorical variables. A repeated-
measure analysis of variance was used to compare vari-
ables over time. When the sphericity assumption has been
violated as assessed by Mauchly’s test, the degrees of
freedom were corrected using Greenhouse-Geisser es-
timates of sphericity. A Bonferroni correction was
used for post hoc tests. Univariate analysis was per-
formed to test associations with postoperative complica-
tions. A logistic regression was performed for multivariate
analysis for all univariate relevant covariates that discrim-
inate between the two groups (P value <0.05 was set as
the limit for inclusion). A hierarchical entry method in
two blocks was used. In the first block, variables usually
known to influence prognosis were entered. In the second
block, all other variables were entered. Receiver operating
characteristic (ROC) curves were generated to identify opti-
mal cut-off values for outcome associations, and the area
under the ROC curve, sensitivity and specificity were calcu-
lated. The optimal threshold value from the ROC curves
was assessed to obtain the highest Youden index and posi-
tive likelihood ratio. A P value less than 0.05 was considered
statistically significant. Statistical analysis was performed
using the SPSS 17.0 software (Chicago, IL, USA).
Results
Between May 2008 and May 2009, 115 patients who
fulfilled the entry criteria were included in the study.
Baseline characteristics of the study population are given in
Table 1. The median American Society of Anesthesiology
Physical Status score was 3.0 (2.0-3.0), mean age was
65 ± 12 years, and 75% were male. At the time of
inclusion (T0), the median SAPS II score was 19.5
(15.0-28.7) and the mean ScvO2 and PCO2 gap were
77.3 ± 6.3% and 7.2 ± 3.3 mmHg, respectively. A total of
43% of patients were mechanically ventilated, and 36%
received catecholamine infusion. The median duration of
mechanical ventilation was 0.0 (0.0-3.0) days. The SOFA
scores were 4.0 (1.0-10.0), 4.0 (1.0-8.0), and 4.0 (1.0-8.0) at
postoperative days 1, 2 and 3, respectively. The median
ICU and hospital length of stays were 6.0 (4.0-8.0) days
and 21.0 (15.0-29.0) days, respectively. The 28-day mortality
rate was 8% (septic shock, n = 4; acute mesenteric
ischemia, n = 2; myocardial infarction, n = 2; massive acute
blood loss, n = 1).
Association with outcome
A total of 78 (68%) patients developed postoperative
complications during their ICU stay, of whom 57 (50%)
patients developed postoperative sepsis and 54 (47%)
patients developed organ failure (Table 2). At the time of





Wound infection 2 (1.7)
Urinary tract infection 1 (0.8)
Acute renal failure 18 (15.7)
Acute cardiac failure 10 (8.7)
Acute myocardial infarction 5 (6.1)
Pulmonary embolism 3 (2.6)
Hemorrhage 14 (12.2)
Lower limb ischemia 11 (9.6)
Data are presented as absolute values (%).
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more likely to undergo urgent surgery (Table 3). There
were no other statistically significant differences in baseline
high-risk criteria between the two patient groups. Patients
with postoperative complications were more severely ill on
ICU admission (SOFA score: 7.0 (3.0-12.0) versus 1.0
(1.0-2.5), P < 0.001; SAPS II score: 23.0 (16.5-31.2)
versus 15.5 (12.0-24.2), P = 0.008), had longer durations of
mechanical ventilation (2.0 (0.0-3.0) days versus 0.0
(0.0-0.0) days, P < 0.001) and longer durations of hospital
stay (25.0 (20.0-34.0) days versus 14.0 (12.0-160), P < 0.001).
On the day of ICU admission, there were statistically
significant differences in lactate level (P = 0.006), but not in
ScvO2 values (P = 0.17) between patients who did and did
not develop postoperative complications. Univariate
analysis identified nine variables on ICU admission
associated with the occurrence of postoperative com-
plications on ICU admission: lactate level (P = 0.006),
troponin level (P = 0.025), bicarbonate level (P = 0.008),
arterial O2 saturation (P = 0.026), urine output (P = 0.023),
PCO2 gap value (P < 0.001), SAPS II (P = 0.008), SOFA
score (P < 0.001) and emergency surgery (P = 0.04).
Multivariate analysis showed that a high PCO2 gap
(odds ratio = 1.93, 95% confidence interval (CI) 1.36 to
2.75, P < 0.001) and a high SOFA score (odds ratio = 1.52
95% CI 1.14 to 2.02, P = 0.004) at H0 were independently
associated with the occurrence of postoperative complica-
tions (Table 4). The same results were observed at H6
(data not shown). The area under the ROC curve for
the occurrence of postoperative complications was
0.86 (95% CI 0.77 to 0.95) for the PCO2 gap. The area
under the ROC curve for organ failure for SOFA score,
SAPS II score, lactate level and troponin value were
0.82, 0.67, 0.67 and 0.57, respectively (Figure 1). The opti-
mal PCO2 gap value on ICU admission was 5.8 mmHg
(sensitivity 90.7%, specificity 70.0%, positive predictive
value 86.6%, and negative predictive value 78.8%) fordiscriminating between patients who did and patients
who did not develop postoperative complications. Of
the 54 patients who developed organ failure, 46 had a
PCO2 gap ≥6 mmHg. A high PCO2 gap (>6 mmHg)
was observed in 68% of the patients upon admission to
the ICU after surgery. Compared with patients with a low
PCO2 gap on ICU admission, a high PCO2 gap was
associated with more organ failure (P < 0.001), and an
increase in duration of mechanical ventilation (P = 0.002)
and length of hospital stay (P < 0.001) (Table 5). In
addition, a high PCO2 gap was associated with a higher
28-day mortality rate (11.5% versus 0%, P = 0.056).
Trends in PCO2 gap
Changes in the PCO2 gap and lactate values during the
first 12 hours are shown in Figure 2. From H0 to H12,
there was a significant difference for mean PCO2 gap (P =
0.001) and mean lactate values (P = 0.003) between pa-
tients who did or did not develop postoperative complica-
tions. Maximal difference was present immediately after
inclusion just after surgery (8.7 ± 2.8 mmHg versus 5.1 ±
2.6 mmHg, P < 0.001). There was a trend towards a de-
creased PCO2 gap all along the first 12 hours of medical
support in the ICU for patients with postoperative compli-
cations (P = 0.064). Similar trends were present for the
lactate level. There was also a significant difference for
mean PCO2 gap (P = 0.003) between patients who
developed organ failure and those who did not (Figure 3).
Discussion
The main finding of our study is that a PCO2 gap >6 mmHg
at ICU admission following major surgery is predictive of
postoperative complications in high-risk surgical patients.
Patients with an enlarged PCO2 gap had more organ
failure, increased durations of mechanical ventilation
as well as length of hospital stay, and a trend towards
higher mortality rates, although the latter did not reach
statistical significance.
To the best our knowledge, this study is the first to
evidence the prognostic significance of an enlarged PCO2
gap at ICU admission in high-risk surgical patients. In
patients who developed postoperative complications, the
increase in PCO2 gap was maximal immediately after ICU
admission and gradually decreased thereafter as a result of
medical support. The diagnostic performance of the PCO2
gap is quite similar to the SOFA score with the huge
advantage of being measurable at patient admission. In
addition, the measurement of the PCO2 gap is much more
responsive than the SOFA score and easy to implement at
the bedside. These results are supported by the results of
a previous study by our group in which an enlarged PCO2
gap was associated with an increased rate of postoperative
complications in patients who remained inadequately
managed by volume loading during an individualized
Table 3 Baseline characteristics of patients who did and did not develop postoperative complications
Variables Patients with postoperative complications Patients without postoperative complications P value
(n = 78) (n = 37)
Severity scores
ASA class 3.0 (2.0-3.0) 3.0 (2.0-3.0) 0.16
ASA class ≥3 (%) 51 (65) 19 (51) 0.150
SOFA 7.0 (3.0-12.0) 1.0 (1.0-2.5) <0.001
SAPS II 23.0 (16.5-31.2) 15.5 (12.0-24.2) 0.008
High-risk criteria (%)
Age, years 64 ± 13 65 ± 10 0.84
Age ≥70 years 30 (38) 12 (32) 0.53
Severe nutritional problems 8 (10) 3 (8) 1.00
Previous respiratory illness 20 (26) 4 (11) 0.07
Chronic renal failure 5 (6) 1 (3) 0.66
Chronic liver failure 6 (8) 1 (3) 0.43
Ischemic heart disease 32 (41) 19 (51) 0.30
Malignant neoplasia 46 (59) 21 (57) 0.82
Major abdominal surgery 52 (67) 30 (81) 0.11
Prolonged surgery ≥8 hours 6 (8) 3 (8) 1.00
Urgent surgery 19 (24) 3 (8) 0.04
Septic surgery 19 (24) 5 (13) 0.18
Vascular clamping ≥1 hour 4 (5) 0 (0) 0.30
Physiological parameters
Mean arterial pressure, mmHg 82 ± 16 85 ± 14 0.30
Urine output, ml/3 hours 266 ± 228 345 ± 258 0.023
Biologic parameters
Serum lactate, mmol/l 1.54(1.1-3.2) 1.06 ± (0.8-1.8) 0.006
Serum bicarbonate, mmol/l 19.6 ± 4.2 21.4 ± 2.7 0.008
Hemoglobin, g/dl 10.4 ± 1.8 10.8 ± 1.7 0.39
Troponin I, ng/ml 0.03 (0.01-0.11) 0.01 (0.00-0.04) 0.025
Arterial pH 7.33 ± 0.08 7.35 ± 0.07 0.47
Venous pH 7.28 ± 0.09 7.30 ± 0.06 0.06
PCO2 gap, mmHg 8.7 ± 2.8 5.1 ± 2.6 <0.001
PcvCO2, mmHg 46.1 ± 6.7 45.9 ± 6.0 0.92
PaCO2, mmHg 37.4 ± 6.5 40.7 ± 6.2 0.09
ScvO2, % 76.3 ± 6.3 78.0 ± 5.2 0.17
SaO2, % 99.2 (98.4-99.5) 98.8 (98.1-99.2) 0.026
PaO2, mmHg 145 (116–175) 135 (110–156) 0.05
PcvO2, mmHg 46.0 (41.7-54.0) 48,0 (40.5-52.0) 0.77
Data are presented as absolute values (%), mean ± standard deviation, or median (interquartile range). Comparison between groups were assessed by Student’s
t test or Mann-Whitney U test when necessary. Significant P values are indicated in bold text. ASA, American Society of Anesthesiology physiological status; PaCO2,
arterial partial pressure of carbon dioxide; PaO2, arterial partial pressure of oxygen; PCO2 gap, central venous-to-arterial carbon dioxide gradient; PcvCO2, central
venous partial pressure of carbon dioxide; PcvO2, central venous partial pressure of oxygen; SaO2, arterial oxygen saturation; SAPS, Simplified Acute Physiology
Score; SOFA, Sequential Organ Failure Assessment; ScvO2, central venous oxygen saturation.
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of previous studies in patients with severe sepsis or
septic shock in which a large PCO2 gap was associated
with higher rates of organ failure and greater mortality[18,21,27]. In all these studies, the thresholds for PCO2
gap values were around 5 to 6 mmHg, as in our study.
The increase in venous PCO2 would reflect a state of
insufficient flow relative to CO2 production [28,29]. Indeed,
Table 4 Logistic regression results: variables associated with the occurrence of postoperative complications
B (SE) Odds ratio 95% confidence interval P
Constant −5.61 (3.50)
PCO2 gap 0.66 (0.18) 1.93 1.36-2.75 <0.001
SOFA score 0.42 (0.15) 1.52 1.14-2.02 0.004
Lactate 0.38 (0.37) 1.47 0.71-3.02 0.300
SAPS II score 0.04 (0.04) 1.04 0.96-1.13 0.347
Emergency surgery 0.09 (1.17) 1.10 0.11-10.80 0.937
Bicarbonate −0.07 (0.11) 0.931 0.75-1.16 0.931
Troponin 1.87 (1.47) 6.50 0.36-117.06 0.204
diuresis 0.0003 (0.002) 1.00 0.997-1.003 0.825
Model χ2 = 54.96, P < 0.001, R2 = 0.50 (Hosmer and Lemeshow), R2 = 0.48 (Cox and Snell), R2 = 0.66 (Nagelkerke). Significant P values are indicated in bold text.
PCO2 gap, central venous-to-arterial difference in carbon dioxide; SAPS II, Simplified Acute Physiology Score II; SE, standard error; SOFA, Sequential Organ
Failure Assessment.
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model, Vallet and colleagues evidenced that the PCO2 gap
increased during low blood flow-induced tissue hypoxia
(ischemic hypoxia) while it remained unchanged during
hypoxemia-induced hypoxia (hypoxic hypoxia) [22]. These
results were confirmed in a mathematical analysis model
[30] and in in vivo conditions in pig [31] and in sheep [9].
These results are also in agreement with those of Bakker
and colleagues [21] who showed that, in patients with
septic shock, the PCO2 gap was smaller in survivors
than in non-survivors, despite quite similar CO, O2
delivery (DO2) and O2 consumption (VO2) values. In
septic shock patients, characterized by an increased PCO2
gap and a low flow state, fluid challenge was found to lower
the PCO2 gap while increasing CO [32]. In contrast, noFigure 1 Discriminant factors of postoperative complications.
Receiver operating characteristic curve comparing the ability of
central venous-to-arterial difference in carbon dioxide (PCO2 gap),
Sequential Organ Failure Assessment (SOFA) score, Simplified Acute
Physiology Score (SAPS) II score, lactate level and troponin level at
baseline to discriminate between patients who did (n = 78) and did
not (n = 37) develop postoperative complications. Areas under the
curve are 0.86; 0.82; 0.67; 0.67 and 0.57, respectively.significant changes in CO and PCO2 gap were found in pa-
tients with normal PCO2, thus confirming the relationship
between an increased PCO2 gap and insufficient flow [32].
In our study, ScvO2 did not allow us to discriminate
between patients with and without postoperative compli-
cations. These results seem to contradict previous studies.
Indeed, recently published data clearly demonstrate that
low ScvO2 during and after major abdominal surgery
is associated with an increased risk of postoperative
complications [7,16,33]. In addition, ScvO2 was part
of early goal-directed therapy protocol algorithms that
have proven their effectiveness in improving the prognosis
of patients [16,34]. As the use of ScvO2 has become
increasingly popular in the management of high-risk
surgical patients, one part of our patients (at the con-
venience of the anesthetist in charge of the patient)
had already been treated using ScvO2 during surgery be-
fore inclusion in the study. The hemodynamics of our pa-
tients were in part optimized, as evidenced by ScvO2
values above 70% in both groups. Another point to con-
sider is that sepsis was the main cause of postoperative
complications in our study (47%). In this situation
where microcirculation failure is frequent, a normalTable 5 Outcome of patients with high and low values of






(n = 78) (n = 37)
Total duration of MV, days 2.0 (0.0-3.2) 0.0 (0.0-0.0) <0.001
Length of ICU stay, days 6.0 (4.0-8.2) 5.0 (4.0-7.5) 0.287
Length of hospital stay, days 22.5 (17.0-32.2) 16.0 (13.0-23.5) 0.002
Organ failure 46 (59.0%) 8 (21.6%) < 0.001
28-day mortality 9 (11.5%) 0 0.056
Areas under the curve are 0.86; 0.82; 0.67; 0.67 and 0.57, respectively. Data are
presented as medians (interquartile range) or absolute value (%). Significant
P values are indicated in bold text. MV, mechanical ventilation; PCO2 gap,
central venous-to-arterial difference in carbon dioxide.
Patients with postoperative complications 









Figure 2 Trends in PCO2 gap and lactate level. (A) Trends in PCO2 gap (mmHg) and (B) trends in lactate level (mmol/l) in patients who did (n = 78;
square markers) and did not (n = 37; circle markers) develop postoperative complications. PCO2 gap, central venous-to-arterial difference in carbon dioxide.
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fusion [12,13,35]. According to the modified Fick equation
applied to CO2, the PCO2 gap is linearly related to CO2
production (VCO2) and inversely related to CO [29].
In situations where the VO2/DO2 relationship is satis-
fied, the flow is sufficient to wash out the CO2 produced
by the tissue even if there is an additional anaerobic VCO2
[22]. Conversely, when blood flow is low, the PCO2 gap
may increase even if there is no increase in VCO2 [31].
Taken together, these factors may explain why, in some of
our patients, the PCO2 gap was increased while ScvO2
was normal and ScvO2 failed to predict postoperative
complications [36].Similarly, lactate levels were not an independent factor
associated with postoperative complications, unlike
the PCO2 gap. This difference is not entirely a surprise
since our surgical patients benefited from immediate
hemodynamic support in the operating room and inten-
sive care. Therefore, these patients were not necessar-
ily in a decompensated state as evidenced by the
small increase in lactate levels (<2.5 mmol/l on average)
and ScvO2 > 70% including patients who present with
postoperative complications. The increase in PCO2 gap
seems only to suggest that there is a hemodynamic
optimization margin for these patients. Moreover, the
PCO2 gap and lactate levels may reflect different events
Patients with organ failure
Patients without organ failure
p = 0.003
Figure 3 Trends in PCO2 gap and organ failure. Trends in PCO2 gap (mmHg) in patients who developed organ failure (n = 54; square markers)
and those who did not (n = 61; circle markers). Results are expressed as means ± 95% confidence interval. PCO2 gap, central venous-to-arterial
difference in carbon dioxide.
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rapid change in PCO2 gap; the lactate level could reflect
the hemodynamic state in the last hours of surgery. If
there was a significant relationship between the rate of
lactate at H0 and intraoperative variables, such as intra-
venous fluids, blood loss, episodes of low mean blood
pressure ≤60 mmHg for more than 10 minutes, and
duration of surgery (data not shown), the strength of
this association is quite relative, since the correlation
coefficients ranged from 0.273 to 0.359. If intra-
operative events influenced the lactate levels at post-
operative ICU admission, they were not the only
explanation.
In this context, when early goal-directed therapy has
reached its objectives including ScvO2 > 70%, the PCO2 gap
could be a useful additional tool to continue processing
hemodynamic optimization. In several studies using a
goal-directed therapy in sepsis, it was demonstrated
that either lactate clearance or PCO2 gap could be
useful for identifying a persistent tissue hypoperfusion
even when ScvO2 goals had been achieved [15,18]. In
surgical patients, it has been shown that an individualized
preload-targeted fluid loading to maintain tissue perfusion
was not sufficient to prevent significant differences in
outcome [37]. Interestingly, the mean PCO2 gap was
larger in patients with complications with a “normalized”
DO2/VO2 ratio (ScvO2 ≥ 71%) than in patients without
complications, with 5 mmHg as the best threshold value.
Associated with these previous studies, our results con-
firm that the PCO2 gap is a useful and additional tool todetect persistent tissue hypoperfusion. Moreover, the
increase in lactate level, another marker of inadequate
VO2/DO2 relationship, is often delayed compared to
other markers such as ScvO2 [16]. In our study the
elevation of the PCO2 gap was very early, starting at
patient inclusion. Part of this increase was probably
secondary to the intraoperative hemodynamic situation.
The PCO2 gap at H0 was significantly higher in patients
undergoing intraoperative catecholamine (6.88 ± 3.16
versus 3.02 ± 8.7, P = 0.006), but this effect appears to
be limited to the most seriously ill patients (those receiving
catecholamines) since there was no correlation between
PCO2 gap at H0 and other intraoperative macrocirculatory
variables (mean arterial pressure, heart rate, blood loss,
fluid loading, blood transfusions, dieresis; data not shown).
Our study has several limitations. First, this was a
single-center study involving patients undergoing major
abdominal surgery. It is therefore uncertain whether our
findings can be extrapolated to other non-abdominal
surgery. Second, we are aware that the number of patients
was relatively small which could limit the external validity
of the study, and that complementary data are needed to
confirm the result. Nevertheless, when we considered that
one measurement of PCO2 ≥ 6 mmHg at inclusion was
associated with the occurrence of postoperative complica-
tions, we found a post-hoc power >90%. Third, the use of
central venous-to-arterial PCO2 difference as a surrogate
for mixed venous PCO2 gap might be a further limitation.
Nevertheless, it has been found that central venous PCO2,
obtained from a simple central blood sample instead of a
Robin et al. Critical Care  (2015) 19:227 Page 9 of 10pulmonary arterial blood sample, is a valuable alternative
to mixed PCO2 and that correlation with CO still exists in
this context [38].
Conclusion
This is the first study concerning the usefulness of
PCO2 gap in high-risk surgical patients at admission in
postoperative ICU confirming previous results established
during a surgical period or in septic patients. There is
strong support for the use of goal-directed therapy,
particularly for fluid resuscitation, with ScvO2 as the
cornerstone of these algorithms. However, once these
objectives are achieved, the PCO2 gap might be a useful
and complementary tool to detect persistent tissue
hypoperfusion that could be included as an additional
step in the algorithms of early goal-directed therapy
protocols. As the design of our study did not formally
link the changes in PCO2 gap with tissue hypoperfusion
or therapeutic change, further studies are needed to
confirm these findings and be extended to other forms
of surgery.
Key messages
 High PCO2 gap values were associated with a higher
rate of postoperative complications in high-risk
surgical patients.
 Threshold value is 6 mmHg.
 In further studies, PCO2 gap could be integrated as
an additional step in the algorithms of goal-directed
therapy.
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